Allen Wolff

Allen Wolff is a declared insider of Ernexa Therapeutics Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 21 May 2015 to 24 March 2021, the count stands at 56 filings.

The open-market record is one-sided, with 5 purchases worth €25k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 51 share grants.

The median purchase comes to €839. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 20% of cases; the median change was -36.8%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 26 March 2021, the filings show a share grant worth €22k in Ernexa Therapeutics Inc. The most recent open-market purchase was published on 14 June 2016, 3,799 days ago. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.